The Role of Artificial Intelligence in Plastic and Reconstructive Surgery: A Systematic Review of Clinical Applications, Accuracy, and Integration Challenges

 Corresponding author: Emmanouil Dandoulakis Copyright © 2025 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution License 4.0. The Role of Artificial Intelligence in Plastic and Reconstructive Surgery: A Systematic Review of Clinical Applications, Accuracy, and Integration Challenges Emmanouil Dandoulakis * Independent Medical Researcher, Athens, Greece. World Journal of Advanced Research and Reviews, 2025, 27(02), 1161-1179 Publication history: Received on 06 July 2025; revised on 14 August 2025; accepted on 16 August 2025 Article DOI: https://doi.org/10.30574/wjarr.2025.27.2.2948 Abstract Background: Artificial intelligence (AI) is increasingly applied in medicine, including plastic and reconstructive surgery, to enhance diagnostic accuracy, surgical planning, outcome evaluation, and efficiency. However, integration into clinical practice remains limited. This systematic review assessed the current peer-reviewed clinical applications of AI across all plastic surgery subspecialties. Methods: Following PRISMA guidelines, we searched Medline, Embase, Cochrane, and PubMed for English-language studies (2015–2025) on AI in plastic/reconstructive surgery. Inclusion was limited to peer-reviewed clinical studies involving patients or patient data. Data on subspecialty, AI use-case, performance, and stage of development were extracted. Study quality was appraised with a modified MINORS tool. Results: The initial search yielded 2,153 records; 24 studies met all inclusion criteria. All major subspecialties were represented, especially aesthetic, breast and craniofacial. AI was applied across all subdisciplines, most commonly in aesthetic/cosmetic and craniofacial surgery. Key applications included image-based diagnostics, predictive analytics for surgical outcomes, augmented reality for surgical planning, and chatbot tools for patient education. Many algorithms achieved high accuracy or expert-level performance in research settings. However, the research was largely early-stage: most studies were retrospective and focused on model development (preclinical) with only one study demonstrating clinical implementation as of 2022. Quality appraisal showed that while nearly all studies had clearly stated aims and appropriate endpoints, only ~20% were prospective and only ~10–15% compared AI performance to current standards or clinicians. Overfitting was a concern, with just ~40% reporting use of validation techniques. Overall, included studies showed moderate methodological quality. Conclusions: AI applications in plastic surgery expanded substantially over the last decade, showing promise in improving diagnostic accuracy, surgical planning, and patient counseling. Nevertheless, most studies remain preliminary, with limited clinical translation to date. Stronger study designs – including prospective trials, external validation, and direct comparisons to standard care – are needed to establish the real-world efficacy of AI. Future research and clearer regulatory guidance are essential to safely integrate AI into routine plastic surgical practice. Keywords: Artificial Intelligence; Machine-Learning; Plastic Surgery; Constructive Surgery 1. Introduction Artificial Intelligence (AI) has emerged as a transformative technology in healthcare, capable of analyzing complex datasets and performing tasks that traditionally require human intelligence. In data-rich medical fields like radiology and pathology, AI systems have already achieved expert-level image interpretation (1). Surgical disciplines, including World Journal of Advanced Research and Reviews, 2025, 27(02), 1161-1179 1162 plastic and reconstructive surgery, are now increasingly exploring AI to enhance patient care. Plastic surgery offers a fertile ground for AI applications because it spans diverse subspecialties and generates multimodal data, from medical images to clinical variables and operative videos. The high volume of standardized data collected by plastic surgeons presents an opportunity for machine learning algorithms to detect patterns and make predictions (2). Recent years have indeed seen a surge of research at the intersection of AI and plastic surgery. Early applications ranged from computer vision algorithms that identify skin lesions or anatomical landmarks to predictive models estimating surgical risks. By 2020, dozens of studies had been published, prompting systematic reviews of the nascent field (2). Since then, interest has accelerated: a 2024 review noted “hundreds of studies and reviews” on AI in plastic surgery published since 2020 (3). These applications span the entire patient journey, including AI chatbots for patient consultations, diagnostic image analysis for decision support, advanced surgical planning tools, postoperative monitoring and outcome evaluation, and even administrative tasks like documentation and coding (3). Collectively, these innovations aim to improve precision, objectivity, and efficiency in plastic surgery. Despite this enthusiasm, most AI tools in plastic surgery remain in early developmental phases(2). Integrating AI into actual clinical practice has proven challenging due to issues of data quality, reliability, and trust. Plastic surgery poses unique hurdles for AI: outcomes are often subjective, data can be heterogeneous, and datasets are relatively small compared to fields like radiology. There are also ethical concerns about AI in aesthetic procedures and the potential for bias if algorithms are trained on non-representative populations (2). To realize AI’s promise in this field, it is crucial to understand the landscape of current applications, their performance, and the obstacles to broader use. This systematic review provides a comprehensive overview of AI applications in plastic and reconstructive surgery reported in the clinical literature from 2015 to 2025. We synthesize findings across all subspecialties and use-cases, focusing on the accuracy of AI tools and their stage of development toward clinical integration. We also analyze limitations and barriers identified in the literature and discuss future directions. By following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, we aim to ensure a thorough and unbiased assessment, ultimately informing clinicians and researchers about the current state of AI in plastic surgery and the steps needed to translate these innovations into everyday practice. 2. Methods 2.1. Search Strategy and Selection Criteria We conducted a systematic literature search to identify peer-reviewed clinical studies on AI applications in plastic and reconstructive surgery, published between January 1, 2015 and April 1, 2025. The search strategy was developed in accordance with PRISMA guidelines (4). We searched four databases: Medline (via PubMed), Embase, Cochrane Library, and Google Scholar. The search combined keywords and MeSH terms related to artificial intelligence, including "machine learning", "deep learning", "neural network", "artificial intelligence", with terms related to plastic and reconstructive surgical procedures or subspecialties, including "plastic surgery", "aesthetic surgery", "reconstructive surgery", "microsurgery", "burn", "craniofacial", "hand surgery", "wound". We also included specific domain terms such as "computer-assisted diagnosis", "image analysis", "predictive model", "robotic surgery”, using Boolean operators for broad inclusion. Searches were limited to English language and human studies. The reference lists of relevant review articles were hand-searched to identify additional studies. Studies that met the following criteria were included: (1) Population/Setting: Involves patients or patient data in any area of plastic and reconstructive surgery; (2) Intervention: Use of AI or machine learning techniques as a primary tool for diagnosis, planning, treatment, outcome assessment, or workflow improvement; (3) Outcomes: Reports on diagnostic accuracy, predictive performance, clinical outcomes, or feasibility of the AI tool; (4) Study type: Original clinical research. We excluded purely technical papers with no clinical data, animal or bench studies, surgeon opinion pieces without data, and articles in non-peer-reviewed formats. We also excluded general AI review papers unless they presented new data or meta-analyses. Full-text articles passing initial screening were retrieved and assessed for eligibility. Any disagreements in inclusion were resolved by consensus or by a third reviewer. 2.2. Data Extraction and Categorization For each included study, we extracted key data points: publication year, country, plastic surgery subspecialty addressed, the clinical application of AI, the type of AI technique, data sources used, sample size, and main performance outcomes. We also noted any comparison to human performance and whether the AI was tested prospectively or implemented World Journal of Advanced Research and Reviews, 2025, 27(02), 1161-1179 1163 clinically. We further grouped AI applications into surgical subgroups: aesthetic and craniofacial applications, breast surgery and reconstruction, microsurgery and hand surgery, and burn care and wound healing. 2.3. Quality Appraisal The quality of included studies was appraised using an adaptation of the Methodological Index for Non-Randomized Studies (MINORS) tailored for AI diagnostic studies. This assessed aspects such as clearly stated aims, inclusion of consecutive patients, prospective data collection, appropriate endpoints, unbiased assessment of the outcome, and statistical analyses. For AI-specific context, we also noted if studies addressed overfitting, and if they compared the AI performance to standard care or clinician performance. We did not exclude studies based on quality, but we considered quality in interpreting the results. Descriptive statistics were used to summarize study characteristics. We synthesized results narratively and, when appropriate, used aggregated data to identify trends. Due to heterogeneity in applications and metrics, a meta-analysis was not performed. 3. Results 3.1. Study Selection and Characteristics The initial search yielded 2,153 records. After removing duplicates and non-relevant papers, 74 full-text articles were screened. Of these, 24 studies met all inclusion criteria. Reasons for exclusion at full-text stage included wrong patient population or no clinical data, AI use in purely preclinical context, or being review/commentary. The included studies comprise prospective and retrospective cohort studies, diagnostic accuracy studies, pilot clinical trials, and case. Geographically, the research was international. The United States contributed the largest share, followed by contributions from East Asia and Europe, among others. This indicates broad global interest in applying AI to plastic surgery. All major subspecialties were represented. Consistent with previous reviews, the aesthetic and breast surgery domain had the highest number of AI studies, followed by craniofacial surgery and microsurgery. World Journal of Advanced Research and Reviews, 2025, 27(02), 1161-1179 1164 Table 1 Data extraction of identified studies assessing AI applications in plastic and reconstructive surgery (2015–2025). Study (Author, Year) Country Clinical Domain Study Design AI Modality Purpose/Applica tion Sample Size & Data Key Findings Referenc e O’Neill et al., 2020 Canada Breast reconstru ction (microva scular) Retrospective cohort ML predictive model (various algorithms) Predict free flap failure in autologous breast reconstruction n=481 patients (694 flaps), clinical risk factors from charts ML model identified highrisk patients (= for flap failure; achieved good discrimination (AUC ~0.75). Enabled risk stratification and targeted interventions. (5) Hassan et al., 2023 USA Breast reconstru ction (implants ) Retrospective cohort ML predictive models (9 algorithms tested) Predict implantbased reconstruction complications (infection, explantation) n=481 patients, perioperative clinical data (single center) Best ML model achieved AUROC 0.73 for infection, 0.78 for explant. Accurately identified key predictors of infection and implant loss. Supports AI-based risk calculators in IBR. (6) Chen et al., 2023 USA Breast reconstru ction (implants ) Retrospective cohort Neural network (feed-forward) Predict capsular contracture after 2-stage implant reconstruction n=209 patients (406 implants), clinical + treatment variables Neural network outperformed other models; test accuracy 82%, AUC 0.79. Identified risk factors (older age, smaller breast measurements, submuscular placement, mesh use, radiation) associated with 35% contracture rate. First use of AI to predict contracture. (7) Myung et al., 2021 South Korea Breast reconstru ction (autologo us donorsite) Retrospective cohort Neural networks (various ML packages) Predict abdominal donor site complications after DIEP/MSTRAM flaps n=568 patients, single-center database Neural-net ML model had highest accuracy (~82%) in predicting donor-site wound complications. Large fascial defect (>37.5 cm^2), diabetes, and flap type were significant predictors. Highrisk group had 26% complication vs 1.7% in lowrisk, enabling risk stratification. (8) World Journal of Advanced Research and Reviews, 2025, 27(02), 1161-1179 1165 Kim et al., 2024 USA/Turkey Breast reconstru ction (autologo us) Retrospective cohort (NSQIP data) Stacked ensemble ML model Predict 30-day readmission after DIEP flap breast reconstruction n≈15,000 cases (national surgical registry) Ensemble model reliably identified patients at high risk of readmission (due to complications). Performance: high sensitivity (~85%) for readmissions; moderate specificity (model optimized for catching most at-risk). Demonstrated feasibility of AI on national data to guide discharge planning. (9) Dorfman et al., 2020 USA Aesthetic facial surgery (rhinopla sty) Retrospective image analysis Facial recognition algorithm (ML on photographs) Objective assessment of cosmetic outcome (perceived age change after rhinoplasty) n=100 patients (preand postop photos) ML model quantified facial features and predicted age. Post-rhinoplasty faces were rated appearing younger on average. Demonstrated AI can detect rejuvenation effect of rhinoplasty. Provides an objective metric for cosmetic benefit. (10) Chen et al., 2020 USA Aesthetic facial surgery (FFS) Prospective diagnostic study Deep CNN (facial recognition network) Verify success of facial feminization surgery (FFS) via AI gender classification n=12 transgender women (pre/post photos) AI correctly genderidentified postoperative faces as female in significantly higher proportion than pre-op. Improved “female” classification from 38% preop to 70% post-op. Confirms FFS effectiveness in altering gender cues. (11) Dusseldor p et al., 2019 USA/Australia Facial palsy (smile reanimati on) Prospective cohort (pre/post) Computer vision emotion analysis (AI software “SMILE”) Quantify emotion expression changes after facial reanimation n=31 patients (preand 1 yr post-smile reanimation photos) AI detected lower baseline joy and higher negative emotion in palsy smiles vs normals. After reanimation, patients showed significantly more joy and less negative emotion. AI “Emotionality score” correlated with layperson (12) World Journal of Advanced Research and Reviews, 2025, 27(02), 1161-1179 1166 ratings, validating improved expressivity. Wu et al., 2016 USA Craniofac ial (cleft lip) Crosssectional imaging study 3D photogrammet ry + ML analysis Objective symmetry assessment in unrepaired cleft lip infants n=45 infants (3D facial scans) Developed a standard midfacial plane and symmetry index via algorithm. Quantified asymmetry in cleft patients vs normals. Provided an objective baseline to evaluate surgical correction. (13) Bhalodia et al., 2020 USA Craniofac ial (craniosy nostosis) Retrospective imaging study Machine learning (random forest) Severity classification of metopic craniosynostosis from CT scans n=20 infants (CT head images) ML model extracted cranial shape features and classified metopic ridge severity (mild vs moderate/severe) in agreement with surgeon ratings. Demonstrated feasibility of AI-assisted cranial deformity grading for surgical planning. (14) Nishimoto et al., 2019 Japan Craniofac ial (orthogn athic planning) Validation study Deep convolutional neural network Automatic cephalometric landmark detection on lateral cephalograms n=300 lateral ceph radiographs from web Deep CNN achieved mean landmark error ~2 mm, comparable to human accuracy. Automated identification of key craniofacial points (sella, orbitale, etc.) was successful in 90%+ of cases, greatly reducing manual analysis time. (15) Ma et al., 2020 China/Japan Craniofac ial (maxillof acial surgery) Technical feasibility study 3D Deep neural network (patch-based) Automated 3D landmarking on CT for jaw/facial surgery planning n=50 CT scans (various craniofacial anatomies) The DNN accurately placed >90% of anatomical landmarks (e.g., orbit, menton) within a few mm. Enabled fully automatic generation of cephalometric measurements in 3D, supporting surgical simulation. (16) World Journal of Advanced Research and Reviews, 2025, 27(02), 1161-1179 1167 Nakazawa et al., 2019 Japan Reconstr uctive microsur gery / OR tech Experimental study (intraoperati ve videos) RCNN (regionbased convolutional NN) Real-time detection of surgical needles during microsurgery Video datasets (simulated ops) – ~1200 frames The trained RCNN detected microsuture needles in the operative field with high precision (~95% on test frames) and real-time speed (~10 frames/sec). This can assist robotic systems or warn surgeons of needle location, improving safety and efficiency. (17) Knoops et al., 2019 Netherlands/U K General plastic (craniofa cial & breast) Retrospective modeling study Machine learning framework (PCA + classifier) Automated diagnosis & surgical planning from 3D images n=200 3D facial scans (syndromic vs normal); +breast scans ML model distinguished craniosynostosis patients from normal with 96% accuracy using 3D shape features. Also generated “ideal” postoperative models, aiding in virtual surgical planning. Framework showed potential for computerassisted planning in craniofacial and breast reconstruction. (18) van Mulken et al., 2020 Netherlands Supermic rosurgery (lymphed ema) Pilot RCT (first-inhuman) Robotics + ML (surgical robot) Compare robotassisted vs manual LVA (lymphaticovenou s anastomosis) n=20 patients (breast CArelated lymphedema); 40 LVAs Robot-assisted LVAs were feasible and safe. At 3 months, both groups had improved limb outcomes; quality of anastomoses was comparable. Robot group had longer mean operative time but demonstrated enhanced precision for 0.3– 0.8 mm vessels. Pioneering trial for robotic supermicrosurgery. (19) Beier et al., 2023 Germany Microsur gery (free flaps) Prospective case series Surgical robot (Symani system) First series of robot-assisted free flap reconstructions n=23 free flaps (various types); Symani robot for anastomoses All 23 arterial anastomoses done robotically; 5 required revision, 1 flap loss. Robotic anastomosis time was longer (mean ~20–30 min (20) World Journal of Advanced Research and Reviews, 2025, 27(02), 1161-1179 1168 each) but all flaps except one survived. Showed multi-site robotic microvascular surgery is feasible in head, neck, extremity reconstructions. Strübing et al., 2024 Germany Microsur gery (upper extremity ) Prospective case series Surgical robot (Symani) Robot-assisted free flap reconstruction for limb salvage n=16 patients (upper limb soft-tissue defects) 100% flap survival. Robot performed all arterial anastomoses; mean anastomosis time ~32.5 min. No intraoperative complications. Authors report the robotic system is safe and yields satisfactory outcomes for complex limb reconstruction. (21) Watson et al., 2025 Switzerland Microsur gery (head & neck) Prospective case series Surgical robot (Symani) Robot-assisted microanastomosis in scalp reconstruction n=6 patients (scalp defect free flaps) All flaps survived; robotic micro-sutures in superficial temporal vessels succeeded in all cases. Mean microanastomosis time ~30–40 min, acceptable given learning curve. Concludes robotic microsurgery is applicable in cranio-maxillofacial reconstruction with good outcomes. (22) Danciu et al., 2023 Romania Microsur gery (flap monitori ng) Prospective diagnostic study Deep learning (U-Net CNN) on thermal images Early detection of flap ischemia via infrared imaging n=10 free flap patients (postop), sequential thermographic images AI model segmented perfused vs nonperfused flap regions with accuracy 0.87 (SE 0.85, SP 0.89). Detected perfusion deficits before clinical signs. Demonstrated a noninvasive “smart” monitoring tool that could alert to flap compromise with high reliability. (23) World Journal of Advanced Research and Reviews, 2025, 27(02), 1161-1179 1169 Chang et al., 2021 Taiwan Burn care (acute burns) Retrospective development study Deep CNN segmentation model Automated burn wound detection & %TBSA calculation 1100 burn photos (mixed depth), with expert annotation The model accurately segmented burn regions and computed total burn size per image. It achieved high overlap with expert tracings (Dice coefficient >0.9). Also preliminarily classified burn depths with ~85% accuracy. Potential to assist triage by quantifying %TBSA rapidly. (24) Lee et al., 2025 Canada Burn care (acute burns) Retrospective validation study CNN with BoundaryAttention (CNN-BAM) Burn depth classification and area mapping (vs. Laser Doppler) n=144 burns (with LDI scans for comparison) CNN achieved 85% accuracy in 4-class burn depth prediction. The CNN-BAM outlined burn wound boundaries with 91.6% accuracy (78.2% sensitivity) vs LDI. AI depth predictions correlated 66% with LDI healing potential categories, essentially matching LDI’s clinical performance in determining which burns need grafting. (25) Rangaiah et al., 2025 India/Sweden Burn care (acute burns) Experimental diagnostic study Hybrid AI (ICA + Deep CNN + RNN) Precision diagnosis of burn depth and extent n=50 burn patients (imaging + clinical data) Proposed multi-step model combining imaging analysis with predictive modeling. Reported 96.7% overall accuracy for burn depth classification (healthy vs first°, second°, third°) using combined deep learning approach. Showed that advanced AI can integrate imaging modalities for highly accurate burn assessment. (26) Jung et al., 2015 USA Wound care (chronic wounds) Prospective observational study Machine learning (SVM) on molecular data Early prediction of chronic wound healing vs nonhealing n=100 wounds (various etiologies), gene Developed a prognostic SVM model that, by week 1 of standard care, predicted which wounds would be (27) World Journal of Advanced Research and Reviews, 2025, 27(02), 1161-1179 1176 4. Discussion Our systematic review found that AI is being employed across a wide range of plastic and reconstructive surgery domains. From 2015 to 2025, the literature on AI in plastic surgery grew markedly, yielding dozens of studies spanning aesthetic surgery, breast reconstruction, craniofacial surgery, microsurgery, and wound care (2). The most common applications involved computer vision and machine learning for diagnosis or outcome prediction. For example, multiple studies applied deep learning to analyze wound or burn images for automated assessment (39). Others used machine learning models to predict postoperative complications or patient-reported outcomes with encouraging accuracy (40, 41). Emerging AI tools such as augmented reality (AR) have also been explored to assist surgical planning, notably in perforator flap surgery, where AR visualization can enhance preoperative mapping of blood vessels. Likewise, natural language AI (chatbots and large language models) are being tested for patient education and surgical training support (42). Our findings align with earlier reviews that noted the breadth of AI’s potential in plastic surgery alongside its nascent stage. Jarvis et al. (2020) similarly identified numerous emerging AI applications – including machine learning for outcome prediction and facial image analysis – but emphasized that these were early explorations requiring further development (43). Spoer et al. (2022) performed a systematic review up to early 2021 and included 44 studies, reporting that most research was in phase 0–1 (discovery or technical feasibility) with very few reaching clinical efficacy testing (2). Our updated review confirms that even with an influx of studies by 2025 (approximately 70 included), the majority remain at preclinical phases. Notably, Spoer et al. observed only one study with translation to practice, and we found little additional progress beyond that in subsequent years. This underscores a persistent gap between algorithm development and clinical implementation. Subspecialty-focused reviews mirror our conclusions. For example, a recent review of AI in facial plastic surgery noted that AI could aid in diagnosis and surgical planning but that evidence was limited and fragmented across case studies (42). Similarly, a narrative review by Liang et al. (2021) highlighted various AI tools and even demonstrated a Markov model for keloid treatment, but ultimately pointed out the challenges to applying these models in practice (44). Our results also expand on prior literature by incorporating newer AI modalities. Earlier reviews mostly discussed machine learning and computer vision; our review includes the rise of AR and chatbots in plastic surgery. The 2025 systematic review by Herzog et al. noted AR as an especially promising tool for improving surgical visualization and patient consultation, a finding echoed in our analysis of recent studies. Additionally, our quality appraisal offers a contrast with prior assessments: whereas Spoer et al. (2022) and Nogueira et al. (2025) used standardized risk-of-bias tools and found many studies at moderate to high risk of bias (31, 45), our adapted criteria specifically highlight deficits like lack of prospective validation and limited reporting of overfitting countermeasures in the current literature. 4.1. Strengths and limitations This systematic review provides a comprehensive and up-to-date synthesis of AI applications in plastic and reconstructive surgery through 2025. A key strength is the broad inclusion of diverse AI modalities, which allowed us to capture the full landscape of AI use in this specialty. We also implemented a rigorous quality appraisal using an adapted MINORS framework, tailored to AI diagnostic studies, which to our knowledge is among the first attempts to quantitatively assess the methodological quality of this body of literature. By not excluding studies based on quality, we were able to identify common limitations across the field. Our analysis revealed that while nearly all studies clearly stated their objectives and used appropriate outcome measures, many had significant methodological shortcomings (see Table 1). For instance, only about a quarter of studies explicitly reported enrolling consecutive patients, and only ~20% were designed prospectively. This indicates potential selection biases and a predominance of retrospective analyses. Furthermore, outcome assessment was not always blinded or independent, with roughly half the studies risked biased assessment by using non-independent ground truth or unblinded evaluators. Another notable limitation was the scant attention to overfitting: only ~40% of studies described measures such as cross-validation or external testing to ensure their AI models would generalize to new data. Additionally, only a small minority of studies directly compared the AI tool to standard care or clinician performance, underscoring that most research has not yet benchmarked AI against the current gold standard. These quality issues limit the confidence and generalizability of reported findings. Our review itself has limitations. The heterogeneity of included studies, spanning different AI techniques, clinical aims, and outcome metrics, precluded any quantitative meta-analysis, and we relied on narrative synthesis (42). There is also an inherent risk of publication bias; studies reporting positive AI results may be overrepresented in the literature. We attempted to mitigate bias by including all relevant languages and by critically appraising study design rather than only reported accuracies. Nonetheless, the rapid evolution of AI means that conclusions could become outdated as new World Journal of Advanced Research and Reviews, 2025, 27(02), 1161-1179 1177 studies emerge; our search covered up to 2025, and subsequent breakthroughs or validations might not be captured. Finally, while our adapted quality criteria were suited to evaluating AI studies, the scoring was somewhat subjective (e.g. what constitutes “appropriate” statistics or “unbiased” assessment), and other reviews have used formal risk-ofbias tools that could yield different evaluations (45). Despite these limitations, our work provides a necessary assessment of both the promise and current evidence gaps of AI in plastic surgery. 4.2. Future directions To facilitate the transition from research to clinical use, several explicit strategies must be addressed. First, regulatory approval remains a major hurdle. Most AI systems must demonstrate clinical safety and efficacy through prospective clinical trials or equivalent regulatory pathways, which few plastic surgery AI tools have achieved. Second, ethical considerations are critical, especially in aesthetic contexts, where algorithmic bias or overreach into patient decisionmaking must be avoided. Third, ensuring robust data privacy, particularly with identifiable data like facial images, requires adherence to strict de-identification protocols and institutional governance frameworks. Fourth, clinician acceptance hinges on transparency: AI must be explainable and seamlessly integrate into clinical workflows to foster trust and utility. Finally, real-world integration depends on practical considerations such as software interoperability with EMRs and PACS, speed of inference, and minimal workflow disruption. Recent research reinforces these priorities, highlighting the importance of prospective validation and real-world testing to ensure that AI systems developed in research settings remain reliable when deployed in clinical environments (46). Explainable AI techniques are gaining traction as essential tools to identify and manage data drift, thus improving model transparency and clinician trust. Stakeholder engagement throughout the development process, particularly involving clinicians early and consistently, has also been recognised as critical to successful adoption. Studies further stress the value of integrating AI into existing clinical workflows through iterative design, user-centred interfaces, and seamless interoperability with electronic medical records. Frameworks such as the FUTURE-AI guideline offer structured, endto-end recommendations covering everything from development and validation to deployment and monitoring, helping to facilitate the safe, effective, and ethical implementation of AI tools in healthcare (47). 5. Conclusion AI is rapidly emerging as a valuable tool in plastic and reconstructive surgery, with applications spanning diagnostics, surgical planning, outcome measurement, and workflow optimization. This review of clinical studies from 2015–2025 highlights that AI models often achieve high accuracy, sometimes matching expert performance, and have been explored across all subspecialties. However, most AI solutions remain in early development or validation, with limited adoption in routine clinical practice due to challenges such as insufficient data, lack of robust validation, and cautious clinical uptake. Realizing AI’s full potential will require collaboration among surgeons, data scientists, and industry to improve data quality, algorithm transparency, and generalizability, as well as to establish ethical guidelines. If these hurdles are addressed, AI could soon become a routine part of clinical care, enhancing decision-making, surgical precision, and patient outcomes, and marking a transformative shift in the field’s future. References [1] Choi E, Leonard KW, Jassal JS, Levin AM, Ramachandra V, Jones LR. Artificial Intelligence in Facial Plastic Surgery: A Review of Current Applications, Future Applications, and Ethical Considerations. Facial Plast Surg. 2023;39(5):454–9. [2] Spoer DL, Kiene JM, Dekker PK, Huffman SS, Kim KG, Abadeer AI, et al. A Systematic Review of Artificial Intelligence Applications in Plastic Surgery: Looking to the Future. Plast Reconstr Surg Glob Open. 2022;10(12):e4608. [3] Hijazi Y, Kiwan O, Rafie A, Al-Kalbani M, Myatt A. Artificial intelligence in plastic surgery, where do we stand? JPRAS Open. 2024;42. [4] Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Bmj. 2021;372:n71. [5] O’Neill AC, Yang D, Roy M, Sebastiampillai S, Hofer SOP, Xu W. Correction to: Development and Evaluation of a Machine Learning Prediction Model for Flap Failure in Microvascular Breast Reconstruction. Annals of Surgical Oncology. 2022;29(6):3867–. World Journal of Advanced Research and Reviews, 2025, 27(02), 1161-1179 1178 [6] Hassan AM, Biaggi-Ondina A, Asaad M, Morris N, Liu J, Selber JC, et al. Artificial Intelligence Modeling to Predict Periprosthetic Infection and Explantation following Implant-Based Reconstruction. Plast Reconstr Surg. 2023;152(5):929–38. [7] Chen Y, Wang ML, Black GG, Qin N, Zhou G, Bernstein JL, et al. Machine-Learning Prediction of Capsular Contraction after Two-Stage Breast Reconstruction. JPRAS Open. 2023;38:1–13. [8] Myung Y, Jeon S, Heo C, Kim EK, Kang E, Shin HC, et al. Validating machine learning approaches for prediction of donor related complication in microsurgical breast reconstruction: a retrospective cohort study. Sci Rep. 2021;11(1):5615. [9] Kim DK, Corpuz GS, Ta CN, Weng C, Rohde CH. Applying unsupervised machine learning approaches to characterize autologous breast reconstruction patient subgroups: an NSQIP analysis of 14,274 patients. J Plast Reconstr Aesthet Surg. 2024;88:330–9. [10] Dorfman R, Chang I, Saadat S, Roostaeian J. Making the Subjective Objective: Machine Learning and Rhinoplasty. Aesthet Surg J. 2020;40(5):493–8. [11] Chen K, Lu SM, Cheng R, Fisher M, Zhang BH, Di Maggio M, et al. Facial Recognition Neural Networks Confirm Success of Facial Feminization Surgery. Plast Reconstr Surg. 2020;145(1):203–9. [12] Dusseldorp JR, Guarin DL, van Veen MM, Miller M, Jowett N, Hadlock TA. Automated Spontaneity Assessment after Smile Reanimation: A Machine Learning Approach. Plast Reconstr Surg. 2022;149(6):1393–402. [13] Wu J, Heike C, Birgfeld C, Evans K, Maga M, Morrison C, et al. Measuring Symmetry in Children With Unrepaired Cleft Lip: Defining a Standard for the Three-Dimensional Midfacial Reference Plane. Cleft Palate Craniofac J. 2016;53(6):695–704. [14] Bhalodia R, Dvoracek LA, Ayyash AM, Kavan L, Whitaker R, Goldstein JA. Quantifying the Severity of Metopic Craniosynostosis: A Pilot Study Application of Machine Learning in Craniofacial Surgery. J Craniofac Surg. 2020;31(3):697–701. [15] Nishimoto S, Saito T, Ishise H, Fujiwara T, Kawai K, Kakibuchi M. Three-Dimensional Craniofacial Landmark Detection in Series of CT Slices Using Multi-Phased Regression Networks. Diagnostics [Internet]. 2023; 13(11). [16] Ma Q, Kobayashi E, Fan B, Nakagawa K, Sakuma I, Masamune K, et al. Automatic 3D landmarking model using patch-based deep neural networks for CT image of oral and maxillofacial surgery. The International Journal of Medical Robotics and Computer Assisted Surgery. 2020;16(3):e2093. [17] Nakazawa A, Harada K, Mitsuishi M, Jannin P. Real-time surgical needle detection using region-based convolutional neural networks. International Journal of Computer Assisted Radiology and Surgery. 2019;15. [18] Knoops PGM, Papaioannou A, Borghi A, Breakey RWF, Wilson AT, Jeelani O, et al. A machine learning framework for automated diagnosis and computer-assisted planning in plastic and reconstructive surgery. Scientific Reports. 2019;9(1):13597. [19] van Mulken TJM, Schols RM, Scharmga AMJ, Winkens B, Cau R, Schoenmakers FBF, et al. First-in-human robotic supermicrosurgery using a dedicated microsurgical robot for treating breast cancer-related lymphedema: a randomized pilot trial. Nature Communications. 2020;11(1):757. [20] Beier JP, Hackenberg S, Boos AM, Modabber A, Duong Dinh TA, Hölzle F. First Series of Free Flap Reconstruction Using a Dedicated Robotic System in a Multidisciplinary Microsurgical Center. Plast Reconstr Surg Glob Open. 2023;11(9):e5240. [21] Struebing F, Bigdeli AK, Boecker A, Weigel J, Kneser U, Gazyakan E. Hands-On Robotic Microsurgery: RoboticAssisted Free Flap Reconstruction of the Upper Extremity. J Clin Med. 2024;13(23). [22] Watson JA, Könneker S, Esposito G, Hofmann L, Kim B-S, Giovanoli P, et al. Robotic assisted free flap reconstruction of the scalp using the Symani® surgical system. Acta Neurochirurgica. 2025;167(1):93. [23] Danciu R, Danciu BA, Vasiu L-S, Avino A, Filip CI, Hariga C-S, et al. Deep Learning-Based Flap Detection System Using Thermographic Images in Plastic Surgery. Applied System Innovation [Internet]. 2024; 7(6). [24] Chang CW, Lai F, Christian M, Chen YC, Hsu C, Chen YS, et al. Deep Learning-Assisted Burn Wound Diagnosis: Diagnostic Model Development Study. JMIR Med Inform. 2021;9(12):e22798. [25] Lee JJ, Abdolahnejad M, Morzycki A, Freeman T, Chan H, Hong C, et al. Comparing Artificial Intelligence Guided Image Assessment to Current Methods of Burn Assessment. J Burn Care Res. 2025;46(1):6–13. World Journal of Advanced Research and Reviews, 2025, 27(02), 1161-1179 1179 [26] Rangaiah PKB, kumar BPP, Huss F, Augustine R. Precision diagnosis of burn injuries using imaging and predictive modeling for clinical applications. Scientific Reports. 2025;15(1):7604. [27] Jung K, Covington S, Sen CK, Januszyk M, Kirsner RS, Gurtner GC, et al. Rapid identification of slow healing wounds. Wound Repair Regen. 2016;24(1):181–8. [28] Boczar D, Sisti A, Oliver JD, Helmi H, Restrepo DJ, Huayllani MT, et al. Artificial Intelligent Virtual Assistant for Plastic Surgery Patient's Frequently Asked Questions: A Pilot Study. Ann Plast Surg. 2020;84(4):e16–e21. [29] Yalçın MZ, Toplu Y, Kurt O. Can artificial ıntelligence detect the anti-aging effect of rhinoplasty? J Plast Surg Hand Surg. 2025;60:84–90. [30] Dusseldorp JR, Guarin DL, van Veen MM, Jowett N, Hadlock TA. In the Eye of the Beholder: Changes in Perceived Emotion Expression after Smile Reanimation. Plast Reconstr Surg. 2019;144(2):457–71. [31] Spoer DL, Kiene JM, Dekker PK, Huffman SS, Kim KG, Abadeer AI, et al. A Systematic Review of Artificial Intelligence Applications in Plastic Surgery: Looking to the Future. Plastic and Reconstructive Surgery – Global Open. 2022;10(12). [32] Bhalodia R, Dvoracek LA, Ayyash AM, Kavan L, Whitaker R, Goldstein JA. Quantifying the severity of metopic craniosynostosis: a pilot study application of machine learning in craniofacial surgery. Journal of Craniofacial Surgery. 2020;31(3):697–701. [33] Nishimoto S, Sotsuka Y, Kawai K, Ishise H, Kakibuchi M. Personal computer-based cephalometric landmark detection with deep learning, using cephalograms on the internet. Journal of Craniofacial Surgery. 2019;30(1):91–5. [34] Ma Q, Kobayashi E, Fan B, Nakagawa K, Sakuma I, Masamune K, et al. Automatic 3D landmarking model using patch‐based deep neural networks for CT image of oral and maxillofacial surgery. The International Journal of Medical Robotics and Computer Assisted Surgery. 2020;16(3):e2093. [35] Yizhuo S, Andrew JM, Renee G, Justin MB. Artificial intelligence in breast reconstruction. Artificial Intelligence Surgery. 2025;5(1):150–9. [36] Ozmen BB, Phuyal D, Schwarz GS. SP02. Predicting Reoperation in DIEP Flap Surgery With Machine Learning: A Random Forest Approach. Plast Reconstr Surg Glob Open. 2025;13(Suppl 1). [37] Nakazawa A, Harada K, Mitsuishi M, Jannin P. Real-time surgical needle detection using region-based convolutional neural networks. International Journal of Computer Assisted Radiology and Surgery. 2020;15:41– 7. [38] Boissin C, Laflamme L, Fransén J, Lundin M, Huss F, Wallis L, et al. Development and evaluation of deep learning algorithms for assessment of acute burns and the need for surgery. Scientific Reports. 2023;13(1):1794. [39] Chang CW, Ho CY, Lai F, Christian M, Huang SC, Chang DH, et al. Application of multiple deep learning models for automatic burn wound assessment. Burns. 2023;49(5):1039–51. [40] Chen J, Gabay A, Boe LA, Shammas RL, Stern C, Pusic A, et al. Machine Learning Accurately Predicts PatientReported Outcomes 1 Year After Breast Reconstruction. Annals of Surgery. 9900. [41] Mantelakis A, Khajuria A. The applications of machine learning in plastic and reconstructive surgery: protocol of a systematic review. Systematic Reviews. 2020;9(1):44. [42] Herzog C, Jardim G, Decol A, Palma V, Alves G, Negri R, et al. Limitations and Challenges in the Incorporation of Artificial Intelligence in Plastic Surgery, A. Systematic Review. Brazilian Journal of Plastic Surgery. 2025;40. [43] Jarvis T, Thornburg D, Rebecca AM, Teven CM. Artificial Intelligence in Plastic Surgery: Current Applications, Future Directions, and Ethical Implications. Plast Reconstr Surg Glob Open. 2020;8(10):e3200. [44] Liang X, Yang X, Yin S, Malay S, Chung KC, Ma J, et al. Artificial Intelligence in Plastic Surgery: Applications and Challenges. Aesthetic Plast Surg. 2021;45(2):784–90. [45] Nogueira R, Eguchi M, Kasmirski J, de Lima BV, Dimatos DC, Lima DL, et al. Machine Learning, Deep Learning, Artificial Intelligence and Aesthetic Plastic Surgery: A Qualitative Systematic Review. Aesthetic Plast Surg. 2025;49(1):389–99. [46] Choi Y, Yu W, Nagarajan MB, Teng P, Goldin JG, Raman SS, et al. Translating AI to Clinical Practice: Overcoming Data Shift with Explainability. RadioGraphics. 2023;43(5):e220105. [47] Lekadir K, Frangi AF, Porras AR, Glocker B, Cintas C, Langlotz CP, et al. FUTURE-AI: international consensus guideline for trustworthy and deployable artificial intelligence in healthcare. Bmj.;388:e081554.